Literature DB >> 2225482

The epidemiology of thyrotoxicosis in New Zealand: incidence and geographical distribution in north Canterbury, 1983-1985.

B E Brownlie1, J E Wells.   

Abstract

In a 3-year (1983-1985) epidemiological study of thyrotoxicosis in North Canterbury, New Zealand, the annual incidence was 25.8 per 100,000 (female 40.7, male 10.5). Thyroid scintiscanning showed that 64% had diffuse hyperplasia (DH), 27% toxic multinodular goitre (TMG), 7% toxic uninodular goitre (TUG), and 2% zero uptake. The calculated annual incidence of toxic diffuse goitre (DH) was 15 per 100,000, and for toxic nodular goitre (TMG and TUG combined) was 8 per 100,000. The age-related incidence for toxic diffuse goitre peaked in middle life whereas toxic nodular goitre showed an increasing incidence with age. There was no significant seasonal variation or rural/urban difference in incidence. Analysis of geocoded addresses did not identify areas of high incidence. The variable duration of symptoms prior to diagnosis limits the search for possible environmental trigger factors. North Canterbury was an endemic goitre area prior to the introduction of iodized salt 50 years ago, and the incidence of toxic nodular goitre is likely to fall in future.

Entities:  

Mesh:

Year:  1990        PMID: 2225482     DOI: 10.1111/j.1365-2265.1990.tb00489.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  13 in total

1.  About thyroxine administration during lithium therapy.

Authors:  N Panza; B Biondi; C Carella; G Lombardi
Journal:  J Endocrinol Invest       Date:  1999-11       Impact factor: 4.256

Review 2.  The incidence and prevalence of thyroid autoimmunity.

Authors:  Donald S A McLeod; David S Cooper
Journal:  Endocrine       Date:  2012-05-29       Impact factor: 3.633

Review 3.  Role of genetic and non-genetic factors in the etiology of Graves' disease.

Authors:  M Marinò; F Latrofa; F Menconi; L Chiovato; P Vitti
Journal:  J Endocrinol Invest       Date:  2014-11-25       Impact factor: 4.256

4.  Increased incidence of thyrotoxicosis after iodine supplementation in an iodine sufficient area.

Authors:  J C Galofré; L Fernández-Calvet; M Ríos; R V García-Mayor
Journal:  J Endocrinol Invest       Date:  1994-01       Impact factor: 4.256

5.  A prevalence of thyroid disorder in Western part of Nepal.

Authors:  Raj Kumar Yadav; Namrata Thapa Magar; Bibek Poudel; Naval Kishor Yadav; Binod Yadav
Journal:  J Clin Diagn Res       Date:  2013-02-01

6.  Results of surgery for toxic multinodular goiter.

Authors:  Antonio Ríos; José M Rodríguez; María D Balsalobre; Nuria M Torregrosa; Francisco J Tebar; Pascual Parrilla
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

Review 7.  Joint genetic susceptibility to type 1 diabetes and autoimmune thyroiditis: from epidemiology to mechanisms.

Authors:  Amanda Huber; Francesca Menconi; Sarah Corathers; Eric M Jacobson; Yaron Tomer
Journal:  Endocr Rev       Date:  2008-09-05       Impact factor: 19.871

8.  The incidence of thyroid function abnormalities and natural course of subclinical thyroid disorders, Tehran, I.R. Iran.

Authors:  H Delshad; L Mehran; M Tohidi; M Assadi; F Azizi
Journal:  J Endocrinol Invest       Date:  2011-09-30       Impact factor: 5.467

9.  Transient psychosis due to painless thyroiditis in a patient with anxiety disorder: a case report.

Authors:  Nobuyuki Kobayashi; Junichi Tajiri; Masahiro Takano
Journal:  J Med Case Rep       Date:  2011-10-31

10.  Safety of AS03-adjuvanted inactivated split virion A(H1N1)pdm09 and H5N1 influenza virus vaccines administered to adults: pooled analysis of 28 clinical trials.

Authors:  David W Vaughn; Harry Seifert; Anne Hepburn; Walthere Dewe; Ping Li; Mamadou Drame; Catherine Cohet; Bruce L Innis; Louis F Fries
Journal:  Hum Vaccin Immunother       Date:  2014-11-21       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.